BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 27750179)

  • 21. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
    Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer.
    Aoki Y; Kanao H; Fusegi A; Omi M; Okamoto S; Tanigawa T; Nomura H; Omatsu K; Tonooka A
    Int J Clin Oncol; 2022 Sep; 27(9):1499-1506. PubMed ID: 35705758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
    He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer: Comparison of Real-Time Fluorescence With Indocyanine Green and Methylene Blue.
    Buda A; Di Martino G; Vecchione F; Bussi B; Dell'Anna T; Palazzi S; Cantù MG; Marchette MD; Milani R
    Int J Gynecol Cancer; 2015 Oct; 25(8):1513-8. PubMed ID: 26397069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series.
    Bizzarri N; Luigi PA; Ferrandina G; Zannoni GF; Carbone MV; Fedele C; Teodorico E; Gallotta V; Gueli Alletti S; Chiantera V; Fagotti A; Scambia G; Fanfani F
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):649-659. PubMed ID: 33000339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of indocyanine green fluorescence guided sentinel lymph node biopsy in vulvar cancer: A systematic review.
    Koual M; Benoit L; Nguyen-Xuan HT; Bentivegna E; Azaïs H; Bats AS
    Gynecol Oncol; 2021 May; 161(2):436-441. PubMed ID: 33551201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer.
    Currie AC; Brigic A; Thomas-Gibson S; Suzuki N; Moorghen M; Jenkins JT; Faiz OD; Kennedy RH
    Eur J Surg Oncol; 2017 Nov; 43(11):2044-2051. PubMed ID: 28919031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic Sentinel Node Mapping in Cervical and Endometrial Malignancies: A Case-Control Study Comparing Two Near-Infrared Fluorescence Systems.
    Buda A; Di Martino G; De Ponti E; Passoni P; Sina F; Reato C; Vecchione F; Giuliani D
    J Minim Invasive Gynecol; 2018 Jan; 25(1):93-98. PubMed ID: 28807805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of near-infrared or fluorescent indocyanine green guided sentinel lymph node mapping in gastric cancer: A systematic review and meta-analysis.
    He M; Jiang Z; Wang C; Hao Z; An J; Shen J
    J Surg Oncol; 2018 Dec; 118(8):1243-1256. PubMed ID: 30380146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the method.
    Bedyńska M; Szewczyk G; Klepacka T; Sachadel K; Maciejewski T; Szukiewicz D; Fijałkowska A
    Arch Gynecol Obstet; 2019 May; 299(5):1373-1384. PubMed ID: 30762108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye.
    Buda A; Crivellaro C; Elisei F; Di Martino G; Guerra L; De Ponti E; Cuzzocrea M; Giuliani D; Sina F; Magni S; Landoni C; Milani R
    Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
    Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
    J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
    Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
    Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial and cervical cancer.
    Pawłowicz P; Dabrowska M; Bartkowiak R; Dabrowski M
    Eur J Gynaecol Oncol; 2017; 38(3):441-443. PubMed ID: 29693887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical re-injection of indocyanine green to improve sentinel lymph node detection in endometrial cancer.
    Maramai M; Achilarre MT; Aloisi A; Betella I; Bogliolo S; Garbi A; Maruccio M; Quatrale C; Aletti GD; Mariani A; Colombo N; Maggioni A; Multinu F; Zanagnolo V
    Gynecol Oncol; 2021 Jul; 162(1):38-42. PubMed ID: 33906784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer.
    Rozenholc A; Samouelian V; Warkus T; Gauthier P; Provencher D; Sauthier P; Gauthier F; Drakopoulos P; Cormier B
    Gynecol Oncol; 2019 Jun; 153(3):500-504. PubMed ID: 30902369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer.
    Holloway RW; Ahmad S; Kendrick JE; Bigsby GE; Brudie LA; Ghurani GB; Stavitzski NM; Gise JL; Ingersoll SB; Pepe JW
    Ann Surg Oncol; 2017 Jul; 24(7):1972-1979. PubMed ID: 28265777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Near-Infrared Sentinel Lymph Node Mapping With Indocyanine Green Using the VITOM II ICG Exoscope for Open Surgery for Gynecologic Malignancies.
    Buda A; Dell'Anna T; Vecchione F; Verri D; Di Martino G; Milani R
    J Minim Invasive Gynecol; 2016; 23(4):628-32. PubMed ID: 26921484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.